No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Pegintron is a brand of pegylated interferon, a type of drug used to treat skin cancer. It is a synthetic form of interferon, a naturally occurring protein that helps the body fight infections and cancer. Pegintron is used to treat melanoma, a type of skin cancer, and is administered as an injection. It works by stimulating the body's immune system to attack cancer cells. It is also used to reduce the risk of melanoma recurrence.
Pegintron is a relatively new drug, having been approved by the US Food and Drug Administration in 2011. It is used in combination with other treatments, such as surgery, radiation, and chemotherapy. It is generally well-tolerated, with few side effects.
The Pegintron market is growing, as more people are diagnosed with skin cancer and seek treatment. It is a competitive market, with several companies offering their own versions of the drug. These include Merck, Roche, and Bristol-Myers Squibb. Show Less Read more
